Allurion Technologies Warrants (ALUR.WS)

• Market cap: $119K
• 1 day: -7.44%
• 5 days: -26.02%
• 1 month: -19.43%
• 3 months: -33.67%
• 6 months: -65.51%
• Year to date: -12.72%
• 1 year: -55.78%
• 5 years: -98.09%
• 10 years: -98.09%
• Sector: Healthcare
• Industry: Medical Instruments & Supplies

About: Allurion Technologies Inc is a medical device company that focuses on creating a weight loss platform to treat overweight patients. Its platform, the Allurion Program, features the world's first and only swallowable, procedure-less intragastric balloon for weight loss and offers access to AI-powered remote patient monitoring tools, a proprietary behavior change program, secure messaging, and video telehealth that are delivered by the Allurion VCS. Its proprietary intragastric balloon, the Allurion Balloon, is in the form of a swallowed capsule that is administered to patients under the guidance of a healthcare provider without surgery, endoscopy, or anesthesia.

Employees: 137